Next Article in Journal
A Pragmatic Approach to Acute Cardiorenal Syndrome: Diagnostic Strategies and Targeted Therapies to Overcome Diuretic Resistance
Previous Article in Journal
Effect of Titanium Artifacts on Cholesteatoma in Magnetic Resonance Imaging After Reconstruction of the Middle Ear
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands—A Case Series from a Tertiary Referral Center

1
Division of Plastic and Reconstructive Surgery, R. Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD 21201, USA
2
Department of Surgery, R. Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD 21201, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(9), 2997; https://doi.org/10.3390/jcm14092997 (registering DOI)
Submission received: 12 February 2025 / Revised: 21 April 2025 / Accepted: 24 April 2025 / Published: 26 April 2025
(This article belongs to the Special Issue Surgical Wound Infections and Management)

Abstract

:
Background: Necrotizing soft tissue infections (NSTIs) of the lower extremities represent a surgical emergency with high morbidity, complex reconstruction, and considerable healthcare demands. Free tissue transfer (FTT) is increasingly utilized for limb salvage in extensive soft tissue defects, yet its implications for hospital resource utilization remain unclear. This study aims to compare clinical outcomes and perioperative resource demands between FTT and local flap (LF) reconstruction in NSTI patients. Methods: A retrospective case series was conducted at a tertiary referral center between September 2022 and January 2025, including eight patients with NSTI of the lower extremity (FTT, n = 4; LF, n = 4). Demographic data, comorbidities, surgical timing, complication profiles, and resource utilization metrics—including operative duration, hospitalization length, and number of procedures—were analyzed. All FTT cases underwent preoperative CT angiography as part of institutional protocol. Results: Mean time to definitive reconstruction was longer in the FTT group (17.25 vs. 8 days, p = 0.15), reflecting staged infection control. FTT procedures demonstrated significantly longer operative times (331.75 vs. 170.25 minutes, p = 0.015), but there was no significant difference in total hospital stay (34.75 vs. 27.71 days, p = 0.65). No cases of flap loss or venous congestion were observed, and outcomes were optimized via delayed dangling protocols. Conclusions: FTT is a viable and effective reconstructive modality for lower extremity NSTIs. Despite increased surgical complexity, FTT did not significantly increase hospital resource utilization, supporting its role in limb preservation among appropriately selected patients.

1. Introduction

Necrotizing soft tissue infections (NSTIs) represent a spectrum of life-threatening conditions affecting the skin and soft tissues, necessitating prompt recognition and urgent medical and surgical intervention [1,2,3,4,5]. While NSTIs can involve any anatomical region, the lower extremities are most frequently affected [4,6,7]. These infections can arise in both immunocompromised and otherwise healthy individuals, often secondary to trauma, prior surgical procedures, or even occur spontaneously. Necrotizing fasciitis (NF), a severe subset of NSTI, demonstrates an estimated incidence ranging from 0.4 to 32.64 cases per 100,000 population [2,8,9,10,11], with diabetes mellitus implicated in approximately one-third of cases [11,12,13,14]. Notably, 38–54% of NF cases involve the lower extremities [11,12], posing significant reconstructive challenges following surgical debridement, given the relative paucity of local tissues available for soft tissue coverage.
The microbial etiology of NSTI is categorized into three distinct types [15,16]. Type I infections are polymicrobial, involving aerobic and anaerobic bacteria, while Type II is characterized by monomicrobial infection, predominantly Streptococcus pyogenes and Staphylococcus aureus, with a more aggressive clinical course. Type III, albeit rare, is caused by Vibrio species, particularly in marine environments, often leading to fulminant sepsis [15,16]. Despite aggressive treatment, NSTIs exhibit high morbidity and mortality rates, with reported fatality rates reaching 33% [17,18,19]. Furthermore, amputation is required in up to 23.5% of cases when surgical debridement is delayed or inadequate [2,20,21,22,23,24,25,26,27].
Following debridement, lower extremity reconstruction is particularly challenging due to the frequent exposure of vital structures such as tendons, bones, and neurovascular elements. Conventional reconstructive approaches, including skin grafting, are often futile in cases with compromised vascularity, leading to poor healing outcomes [28]. Free tissue transfer (FTT) has emerged as a cornerstone of limb salvage in such scenarios, facilitating single-stage reconstruction, reducing hospital length of stay, and optimizing functional rehabilitation [29,30,31,32,33,34]. The anterolateral thigh (ALT) flap and other fasciocutaneous, musculocutaneous, or osteocutaneous flaps provide robust vascularity, minimal donor site morbidity, and versatile coverage options [35,36].
Despite its advantages, FTT in NSTI patients is fraught with challenges. The optimal timing of reconstruction remains debated—early flap placement may risk persistent infection, while delayed reconstruction prolongs wound healing and functional impairment. Additionally, patients with NSTIs frequently present with systemic inflammatory response syndrome (SIRS), hemodynamic instability, and multiple comorbidities, all of which increase surgical risk [7,37,38]. The necessity of harvesting a donor site in critically ill patients further complicates decision-making and requires a judicious surgical approach [39,40,41,42].
This study aims to evaluate the safety and efficacy of FTT in lower extremity NSTI reconstruction, particularly in medically complex patients. We present our institutional experience comparing outcomes between FTT and local flap (LF) reconstructions, with an emphasis on clinical outcomes, and healthcare resource utilization. Specifically, we assess whether FTT contributes to improved limb salvage without exacerbating morbidity or significantly prolonging hospital length of stay.

2. Hypothesis

This study investigates the following hypotheses: free tissue transfer (FTT) can be effectively utilized for the reconstruction of necrotizing fasciitis (NF) wounds of the lower extremity without leading to significant complications, such as flap failure or the need for additional reoperations. Furthermore, FTT can provide a reliable and safe reconstructive option for complex post-debridement wounds in NF cases without markedly increasing resource utilization, including hospital length of stay or the number of required surgical interventions.
While local flap reconstruction is typically reserved for cases with more limited soft tissue loss, and free tissue transfer is indicated in more extensive defects, we included both groups to reflect the full clinical spectrum of NSTI-related lower extremity reconstruction. This allowed for an internal reference point on surgical complexity, resource use, and postoperative course, recognizing that these groups differ in baseline severity and reconstructive indication. Our intention is not to equate these techniques, but to provide comparative context for institutional planning and outcomes evaluation.

3. Methods

3.1. Patient Selection

Following Institutional Review Board (IRB) exempt review (HP-00113288) at the University of Maryland, a retrospective review of health records was conducted to identify cases of lower limb necrotizing fasciitis (NF). Case identification was performed using the International Classification of Diseases (ICD)-10-CM codes for necrotizing fasciitis (M72.6) and myositis (M60). All identified cases underwent a comprehensive chart review to confirm the diagnosis of NF, ensuring that necrotic fascia was documented intraoperatively by the attending surgeon. To validate cases requiring free tissue transfer (FTT), patient records were cross-referenced with our institutional clinical registry of all FTT procedures, thereby ensuring data integrity and completeness.
This study was conducted at the R. Adams Cowley Shock Trauma Center and included cases managed between September 2022 and January 2025, in collaboration with the Divisions of Plastic Surgery and Soft Tissue Surgery within the Department of Surgery. The multidisciplinary nature of this approach provided a robust dataset for analysis.
The following de-identified patient variables were recorded for analysis: demographic data, including age and sex; surgical data, including type and size of the flap used, number of surgeries prior to flap surgery, duration of flap surgery, number of flap-related complications, number of flap failures, and hospital length of stay. NF-specific data were also collected, including anatomical site(s) affected, precipitating injury type, suspected causative infectious organism(s) based on culture results, and associated medical comorbidities. The comorbidities examined included age ≥ 50 years, smoking history, diabetes mellitus, hypertension and/or dyslipidemia (defined as requiring lipid-lowering therapy), and morbid obesity (BMI ≥ 35 kg/m2). Arterial perfusion to the lower extremities was initially assessed through physical examination, including palpation of distal pulses and evaluation of capillary refill. At our institution, all patients undergoing free tissue reconstruction for lower extremity defects undergo preoperative computed tomography angiography (CTA) as part of their standard vascular workup to evaluate arterial patency and map perforator anatomy. In cases where CTA raises concerns regarding aberrant anatomy or compromised inflow, formal catheter-based angiography is performed to further delineate vascular anatomy and guide surgical planning.

3.2. Data Analysis

Patient data were systematically compiled using Microsoft Excel, and statistical analysis was performed using STATA 17.0. Descriptive statistics were calculated for all variables. Normality was assessed using the Shapiro–Wilk test. Continuous variables were compared using Student’s t-test (normally distributed) or the Wilcoxon rank-sum test (non-normal distributions). Categorical variables were analyzed using Fisher’s exact test. A p-value < 0.05 was considered statistically significant.

4. Results

A total of eight patients with necrotizing fasciitis (NF) of the lower extremities that were admitted to our center required soft tissue coverage with vascularized tissue. Patients who underwent free tissue transfer (FTT) (n = 4; 1 female, 3 male) were compared with those who were hospitalized for NF but only required a local flap (LF) as part of their reconstruction (n = 4; 2 females, 2 male) (Table 1 and Table 2). The etiologies of NF included penetrating trauma (n = 2), surgical site infection (n = 1), blunt trauma (n = 1), pre-existing skin conditions (n = 2), and pressure ulcers secondary to paraplegia (n = 2). Five patients underwent duplex ultrasonography to assess lower extremity perfusion, and three of these underwent further evaluation with CT angiography. One patient was found to have clinically significant arterial obstruction, which was managed conservatively without need for endovascular or open revascularization.
Group A β-hemolytic Streptococcus pyogenes (GABS) was identified in the wound cultures of one patient in each cohort. In the LF group, wound cultures were positive in three of four patients, revealing a broader polymicrobial burden. Isolated pathogens included Streptococcus dysgalactiae, Eggerthia catenaformis, Streptococcus anginosus, Arcanobacterium haemolyticum, Schaalia radingae, and Pseudomonas aeruginosa. A comparative summary of the identified microorganisms across cohorts is provided in Table 3, highlighting a higher microbial diversity in the LF group, which may have implications for reconstructive planning and infection control strategies. Among the eight patients included in this case series, three (37.5%) had a documented diagnosis of diabetes mellitus—two of whom underwent local flap reconstruction and one who received a free tissue transfer. The most common comorbidities across the cohort were arterial hypertension (n = 5), obesity (n = 4), diabetes mellitus (n = 3), and chronic kidney disease (n = 2). In the local flap group (n = 4), comorbid conditions included arterial hypertension in three patients, diabetes mellitus in two, obesity in three, and chronic kidney disease in one. In the free flap group (n = 4), arterial hypertension was observed in two patients, diabetes mellitus in one, obesity in one, and chronic kidney disease in one. These comorbidities—well-established risk factors for necrotizing soft tissue infections (NSTIs)—may have influenced both the severity at presentation and the postoperative recovery trajectory. However, due to the limited sample size, formal subgroup analysis was not statistically feasible, and, as such, comparisons between groups should be interpreted with caution.
All patients received empiric broad-spectrum intravenous antibiotics upon diagnosis of necrotizing soft tissue infection, in accordance with institutional infectious disease protocols. The initial empiric regimens typically included a combination of vancomycin, piperacillin-tazobactam, and clindamycin. Antibiotic therapy was subsequently tailored based on wound culture sensitivities and infectious disease consultation. For patients with culture-confirmed monomicrobial Streptococcus pyogenes or other streptococcal species, penicillin derivatives were administered when appropriate. In polymicrobial infections, regimens were adjusted to cover anaerobic and Gram-negative organisms as indicated, with agents such as meropenem or cefepime used in select cases. Antibiotic treatment was maintained for a duration determined by infection severity, culture results, and clinical response, typically ranging from 10 to 21 days. Prophylactic antibiotics were also administered perioperatively during reconstructive procedures to minimize surgical site infection risk.
The timing of the flap procedure was determined based on patient stability, infection control, and minimization of necrotic tissue. Among the four flaps performed, three were chimeric or musculocutaneous anterolateral thigh (ALT) flaps incorporating the vastus lateralis (VL) muscle, while one was a latissimus dorsi (LD) flap utilized for definitive reconstruction (Table 1). Patient 3 (ID:3), a 35-year-old male with a surgical site infection, underwent reconstruction with a chimeric ALT-VL flap (muscle flap size: 16 × 6 cm, skin island size: 36 × 11 cm) after extensive debridement of the left lower extremity (Figure 1). Postoperatively, the patient achieved complete flap integration with no complications (Figure 2). No complications were observed at the FTT recipient sites. However, donor site complications in the FTT cohort included hematoma (n = 1) and infection (n = 1). In contrast, the only complication in the LF cohort was wound dehiscence (n = 1), which was managed conservatively with local wound care and antibiotics.
Comparative analysis revealed no statistically significant difference in the mean age between the two cohorts (p = 0.78). The only statistically significant difference between groups was the duration of surgery, which was longer in the FTT cohort (p < 0.05). No significant difference was found in total hospital length of stay between the FTT and LF groups (34.75 vs. 27.71 days, p = 0.65) (Table 4).
FTT procedures were performed at a mean of 17.25 days post admission, whereas definitive surgery in the LF group occurred at a mean of 8 days post admission (p = 0.15) (Table 4). Patients in the FTT group underwent a mean of 4.25 procedures prior to free tissue transfer, compared to a mean of 2.5 procedures in the LF group before definitive local flap coverage. Finally, no significant difference was observed between cohorts in the total number of surgeries/debridements required to achieve disease control (7.75 vs. 5.5, p = 0.63) (Table 4).

5. Discussion

The initial management of necrotizing fasciitis (NF) necessitates multiple debridements, potentially leading to significant soft tissue loss and, in severe cases, limb amputation [18]. Achieving stable wound coverage is essential for optimizing functional recovery and reducing the risk of secondary infections. Free tissue transfer (FTT), a cornerstone of reconstructive surgery for nearly four decades [43,44], was initially reserved for select cases when traditional reconstructive methods were insufficient [35]. However, with advancements in microsurgery, FTT has become a preferred approach, demonstrating success rates approaching 100% in specialized centers [45,46]. In our cohort, we successfully employed microvascular FTT for NF reconstruction without encountering any flap losses. For instance, Patient 3 (ID:3) demonstrated robust soft tissue coverage and functional recovery after ALT-VL flap reconstruction (Figure 2), underscoring the utility of FTT in complex defects.
A key advancement in lower limb salvage is the emphasis on early free flap reconstruction (FFR). The timing of FTT plays a crucial role in optimizing outcomes. Studies suggest that early intervention (within 24–48 h) in lower extremity injuries reduces hospital stays, lowers infection rates [47,48], and improves functional outcomes [49]. However, in the case of NSTI, successful reconstruction hinges more on adequate infection control prior to FTT to mitigate the risk of flap failure. Our findings indicate that the paradigm of early soft tissue coverage following lower extremity trauma does not hold in the context of NF, as the mean time from admission to flap surgery was 17.25 (±7.63) days in the FTT group and 8 (±6.04) days in the local flap cohort. This delay in NF-related reconstruction contrasts with the 48 h window often deemed optimal for lower limb salvage in trauma cases [48], but holds relevance with other case series from other centers investigating the outcomes of FTT in NF management [4]. Although no statistically significant differences were observed in preoperative hospitalization duration (p = 0.15), a trend toward prolonged hospitalization was noted in the FTT cohort (17.25 vs. 8 days). This likely reflects the need for systemic optimization and multiple operative debridements to achieve adequate infection control prior to definitive microsurgical reconstruction. In contrast, patients who underwent local flap (LF) procedures likely had less extensive disease, resulting in smaller soft tissue defects that permitted earlier intervention and shorter preoperative hospitalization. This trend is further supported by the difference in the mean number of debridement procedures required before flap coverage, with LF-treated cases requiring fewer debridements compared to the FTT cohort (2.5 vs. 4.25 surgeries). These findings underscore the critical role of patient selection and surgical timing in NF reconstruction, emphasizing that FTT is often reserved for more complex cases where additional time is required for infection control and wound bed optimization.
When evaluating hospital resource utilization, including total length of stay and number of surgical interventions, our findings suggest that FTT can be safely used for NF wound coverage without significantly increasing hospital resource consumption. However, this study has limited statistical power due to the small sample size. Despite the high volume of NSTI cases at our institution, NF of the lower extremities remains rare, limiting generalizability. This introduces the potential for type II error, wherein a true difference in outcomes may not have been detected [50]. While our study did not achieve statistical significance, we observed a clinically meaningful trend toward shorter hospital duration in the local flap cohort (34.75 vs. 27.71 days, p = 0.65). These findings warrant further investigation through larger, multicenter prospective studies to refine evidence-based reconstructive strategies in NF management. Furthermore, while our study compared reconstructive options, future investigations should also include amputation (e.g., below-knee amputation) as a comparator to comprehensively evaluate resource utilization and functional outcomes.
Donor site complications were observed in two FFT patients: one with a superficial wound infection and one with a hematoma. These were managed conservatively without surgical reintervention and had a limited impact on resource utilization. In the LF cohort, one patient developed wound dehiscence, which was similarly managed with local wound care and pressure relief, also without additional operative intervention. While these complications increased the need for focused postoperative management, they did not significantly alter the overall hospitalization course or resource burden in either group.
Postoperative infection control remains a critical factor in reconstructive success. Initial broad-spectrum antibiotic coverage, followed by targeted therapy based on culture results, is widely accepted [15,16]. Interestingly, only one patient in the FTT group had identified wound pathogens (Streptococcus pyogenes and Escherichia coli), whereas three patients in the LF group had culture-positive wound infections. The microorganisms identified in the LF group included Streptococcus dysgalactiae, Eggerthia catenaformis, Streptococcus anginosus, Arcanobacterium haemolyticum, and Schaalia radingae—notable findings given that some of these pathogens have not been widely reported in NF cases [51]. Additionally, one case involved multidrug-resistant Pseudomonas aeruginosa, highlighting the diverse microbial spectrum associated with NF wounds [52,53].
Another critical rehabilitation strategy in NF-related free tissue transfer (FTT) is the implementation of a progressive venous pressure exposure protocol, commonly referred to as the dangling protocol, to optimize venous drainage and prevent venous congestion—key factors for flap survival [54,55,56,57,58,59,60,61,62,63]. At our institution, strict extremity elevation is enforced immediately postoperatively, with a gradual initiation of the dangling protocol beginning on postoperative day 10. The duration of exposure is progressively increased over four weeks until full weight bearing is achieved without restriction.
There is ongoing debate regarding the optimal timing of venous pressure exposure, with proponents of both “early” and “delayed” dangling protocols [59,64,65,66,67]. However, current protocols primarily focus on microvascular FTT in lower extremity reconstruction without considering the etiology of the underlying defect. Given the history of necrotic tissue debridement and the potential for residual bacterial load in NF cases, we adopted a more conservative approach, prioritizing optimal flap integration before subjecting the limb to venous pressure changes. This delayed dangling strategy was aimed at mitigating the risk of venous congestion and ensuring maximal flap take. Our protocol was highly effective, with no cases of venous congestion or flap loss observed. In addition, early range of motion (ROM) exercises were initiated to preserve joint mobility and prevent long-term functional deficits, particularly in cases with bone or tendon exposure. This approach underscores the need for condition-specific rehabilitation protocols in microsurgical limb reconstruction, particularly in the context of infection-driven defects such as NF.
There is substantial evidence highlighting the adverse effects of opioids and their potential for long-term dependence [68]. Given the need for effective pain management, particularly during frequent and painful dressing changes in this patient population, we implemented a multimodal analgesia strategy centered around regional anesthesia with continuous nerve block catheters (e.g., femoral or sciatic nerve blocks) to provide prolonged postoperative pain control. This catheter-based approach offers sustained analgesia, significantly reducing opioid consumption and its associated adverse effects while facilitating early mobilization. Compared to epidural anesthesia, regional techniques are less invasive, have a lower risk of complications, and provide targeted pain relief with superior patient tolerance. While well-established across various surgical disciplines [69,70,71,72], the application of regional anesthesia in the postoperative management of NSTI reconstruction remains relatively novel. At our institution, this protocol has become the standard of care for NF cases, proving particularly advantageous in mitigating procedural pain and enhancing overall patient comfort and recovery.
Beyond pain management, optimizing functional and aesthetic outcomes following FTT often necessitates secondary procedures, including flap contouring, debulking, and orthopedic interventions such as manipulation under anesthesia (MUA) for joint stiffness or bone exposure [73,74,75]. However, in our cohort, no additional surgeries were required to refine limb function or aesthetics. This may be attributed to the anatomical distribution of NF cases, as only one patient required ankle reconstruction, a region where bulk reduction is often necessary for proper footwear accommodation. In this instance, an anterolateral thigh (ALT) flap was employed, incorporating a fasciocutaneous component with a segment of vastus lateralis (VL) muscle to provide robust bone coverage while minimizing excess volume, thereby eliminating the need for secondary revisions. These findings underscore the importance of precise intraoperative planning in achieving optimal reconstructive outcomes while reducing the burden of additional interventions, further reinforcing the utility of microsurgical reconstruction in complex NF cases.
Lastly, there remains limited data on the influence of comorbidities on FTT outcomes in NF or whether FTT necessitates additional healthcare resources. Gawaziuk et al. conducted the largest case series on FTT in NF patients, analyzing individuals who underwent FTT over a six-year period [4]. Our study corroborates their findings, demonstrating comparable comorbidities and resource utilization between FTT and LF patients, with universally successful outcomes and minimal complications. NF patients frequently present with diabetes mellitus, obesity, and smoking history—factors known to increase flap failure risk [7]. Despite these challenges, our findings support the efficacy of FTT in achieving durable reconstruction and limb preservation when meticulous debridement and perioperative optimization are ensured.

6. Limitations

This study is subject to inherent limitations due to its retrospective case-series design and small sample size, which constrain statistical power and increase the risk of type II error, potentially obscuring true differences between groups [50,76,77]. While NF of the lower extremity requiring FTT is a rare clinical entity, limiting large-scale study feasibility, our findings remain clinically meaningful given the complexity and acuity of this patient population. Although comorbidities such as diabetes mellitus, arterial hypertension, obesity, and chronic kidney disease were documented and descriptively reported, the limited cohort size precluded formal subgroup analyses to determine their specific influence on reconstructive strategy or outcomes. Epidemiologically, such analyses in small samples risk generating spurious or underpowered associations due to inflated variance and model overfitting. Therefore, while these conditions likely influenced initial presentation and healing trajectories, the study design does not allow for definitive causal inferences regarding their impact.
Additionally, the lack of statistical significance in some comparisons should not discount observed clinical trends, which may become significant in larger, hypothesis-driven cohorts. Despite these constraints, our institution’s sustained clinical experience in managing complex NF cases contributes to the internal validity and translational value of the findings. Future multicenter prospective studies with larger sample sizes and standardized reporting of comorbid conditions are warranted to refine patient selection criteria, reconstructive algorithms, and outcome benchmarking.
This study assesses clinical resource utilization based on surrogate endpoints, including operative time, number of surgical interventions, and total hospital length of stay. While informative, these metrics do not constitute a formal economic analysis. A cost-effectiveness evaluation would require access to detailed direct and indirect cost data, the valuation of clinical outcomes, and modeling across relevant time horizons [78]—all of which fall beyond the scope of this retrospective case series. Future research employing prospective designs, economic datasets, or health economic modeling frameworks will be essential to further elucidate the financial implications of complex reconstructive strategies in NSTI management.

7. Conclusions

The utilization of microsurgical free tissue transfer has significantly advanced the management of lower extremity reconstruction following necrotizing soft tissue infections (NSTI). At the R. Adams Cowley Shock Trauma Center, our multidisciplinary team has gained valuable experience in reconstructing NF of the lower extremity, focusing on optimal flap selection, infection control, pain management, and rehabilitation. These efforts have led to improved functional outcomes, limb preservation, and patient satisfaction. Our findings suggest that FTT is a viable reconstructive option for NF patients without significantly increasing resource utilization. Further studies with larger sample sizes are necessary to validate these findings and refine best practices for NF-related limb salvage.

Author Contributions

Study concept and design: G.K. and G.A.L. Acquisition, analysis, and interpretation of data: G.K. and G.A.L. Statistical analysis: G.K. Administrative, technical, or material support: G.K. and G.A.L. Drafting of the manuscript: G.K. Critical revision of the manuscript for important intellectual content: G.K., M.P.G., S.H. and G.A.L. Study supervision: G.A.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Our study received an exempt review (HP-00113288, 2022-09-01) from the Institutional Review Board of the University of Maryland.

Informed Consent Statement

Patient consent was waived for the retrospective analysis of anonymized clinical data and the use of non-identifiable clinical images under Institutional Review Board approval (HP-00113288). All data and images were anonymized to protect patient confidentiality.

Data Availability Statement

The data presented in this study are available in the article and tables. Raw data are not publicly available due to privacy and ethical restrictions imposed by the Institutional Review Board (HP-00113288, approved on 2025-02-03).

Acknowledgments

We extend our gratitude to Lindsay Burns, NP, for her invaluable contribution to patient data identification during the study. Her expertise was instrumental in streamlining the data collection process.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Endorf, F.W.; Klein, M.B.; Mack, C.D.; Jurkovich, G.J.; Rivara, F.P. Necrotizing soft-tissue infections: Differences in patients treated at burn centers and non-burn centers. J. Burn Care Res. 2008, 29, 933–938. [Google Scholar] [CrossRef]
  2. Stevens, D.L.; Bryant, A.E. Necrotizing soft-tissue infections. N. Engl. J. Med. 2017, 377, 2253–2265. [Google Scholar] [CrossRef]
  3. Wall, D.B.; Klein, S.R.; Black, S.; de Virgilio, C. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J. Am. Coll. Surg. 2000, 191, 227–231. [Google Scholar] [CrossRef] [PubMed]
  4. Gawaziuk, J.P.; Liu, T.; Sigurdson, L.; Buchel, E.; Hayakawa, T.E.; Shiga, S.; Logsetty, S. Free tissue transfer for necrotizing fasciitis reconstruction: A case series. Burns 2017, 43, 1561–1566. [Google Scholar] [CrossRef] [PubMed]
  5. Hodgins, N.; Damkat-Thomas, L.; Shamsian, N.; Yew, P.; Lewis, H.; Khan, K. Analysis of the increasing prevalence of necrotising fasciitis referrals to a regional plastic surgery unit: A retrospective case series. J. Plast. Reconstr. Aesthetic Surg. 2015, 68, 304–311. [Google Scholar] [CrossRef]
  6. Bernal, N.P.; Latenser, B.A.; Born, J.M.; Liao, J. Trends in 393 necrotizing acute soft tissue infection patients 2000–2008. Burns 2012, 38, 252–260. [Google Scholar] [CrossRef] [PubMed]
  7. Tunovic, E.; Gawaziuk, J.; Bzura, T.; Embil, J.; Esmail, A.; Logsetty, S. Necrotizing fasciitis: A six-year experience. J. Burn Care Res. 2012, 33, 93–100. [Google Scholar] [CrossRef]
  8. Khamnuan, P.; Chongruksut, W.; Jearwattanakanok, K.; Patumanond, J.; Tantraworasin, A. Necrotizing fasciitis: Epidemiology and clinical predictors for amputation. Int. J. Gen. Med. 2015, 8, 195–202. [Google Scholar]
  9. Allaw, F.; Wehbe, S.; Kanj, S. Necrotizing fasciitis: An update on epidemiology, diagnostic methods, and treatment. Curr. Opin. Infect. Dis. 2024, 37, 105–111. [Google Scholar] [CrossRef]
  10. Trent, J.T.; Kirsner, R.S. Diagnosing necrotizing fasciitis. Adv. Ski. Wound Care 2002, 15, 135–138. [Google Scholar] [CrossRef]
  11. Glass, G.E.; Sheil, F.; Ruston, J.C.; Butler, P.E.M. Necrotising soft tissue infection in a UK metropolitan population. Ann. R. Coll. Surg. Engl. 2015, 97, 46–51. [Google Scholar] [CrossRef]
  12. Tsitsilonis, S.; Druschel, C.; Wichlas, F.; Haas, N.P.; Schwabe, P.; Bail, H.J.; Schaser, K.D. Necrotizing fasciitis: Is the bacterial spectrum changing? Langenbeck Arch. Surg. 2013, 398, 153–159. [Google Scholar] [CrossRef] [PubMed]
  13. Miller, L.G.; Rieg GPerdreau-Remington, F.; Mehdi, S.; Perlroth, J.; Bayer, A.S.; Tang, A.W.; Phung, T.O.; Spellberg, B. Necrotizing fasciitis caused by community-associated methicillin-resistant staphylococcus aureus in Los Angeles. N. Engl. J. Med. 2005, 352, 1445–1453. [Google Scholar] [CrossRef] [PubMed]
  14. Bucca, K.; Spencer, R.; Orford, N.; Cattigan, C.; Athan, E.; McDonald, A. Early diagnosis and treatment of necrotizing fasciitis can improve survival: An observational intensive care unit cohort study. ANZ J. Surg. 2013, 83, 365–370. [Google Scholar] [CrossRef]
  15. Fontes Jr, R.A.; Ogilvie, C.M.; Miclau, T. Necrotizing soft-tissue infections. JAAOS J. Am. Acad. Orthop. Surg. 2000, 8, 151–158. [Google Scholar] [CrossRef] [PubMed]
  16. Ahn, C. Necrotizing fasciitis: Reviewing the causes and treatment strategies. Adv. Ski. Wound Care 2007, 20, 288–293. [Google Scholar]
  17. Wong, C.H.; Chang, H.C.; Pasupathy, S.; Khin, L.W.; Tan, J.L.; Low, C.O. Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality. JBJS 2003, 85, 1454–1460. [Google Scholar] [CrossRef]
  18. Golger, A.; Ching, S.; Goldsmith, C.H.; Pennie, R.A.; Bain, J.R. Mortality in patients with necrotizing fasciitis. Plast. Reconstr. Surg. 2007, 119, 1803–1807. [Google Scholar] [CrossRef]
  19. Tiu, A.; Martin, R.; Vanniasingham, P.; MacCormick, A.D.; Hill, A.G. Necrotizing fasciitis: Analysis of 48 cases in south auckland, new zealand. ANZ J. Surg. 2005, 75, 32–34. [Google Scholar] [CrossRef]
  20. Angoules, A.G.; Kontakis, G.; Drakoulakis, E.; Vrentzos, G.; Giannoudis PVGranick, M.S. Necrotising fasciitis of upper and lower limb: A systematic review. Injury 2007, 38, S18–S25. [Google Scholar] [CrossRef]
  21. Ryssel, H.; Germann, G.; Kloeters, O.; Radu, C.A.; Reichenberger, M.; Gazyakan, E. Necrotizing fasciitis of the extremities: 34 cases at a single centre over the past 5 years. Arch. Orthop. Trauma Surg. 2010, 130, 1515–1522. [Google Scholar] [CrossRef]
  22. Khanna, A.K.; Tiwary, S.K.; Kumar, P.; Khanna, R.; Khanna, A. A case series describing 118 patients with lower limb necrotizing fasciitis. Int. J. Low. Extrem. Wounds 2009, 8, 112–116. [Google Scholar] [CrossRef] [PubMed]
  23. Rieger, U.M.; Gugger, C.Y.; Farhadi, J.; Heider, I.; Andresen, R.; Pierer, G.; Scheufler, O. Prognostic factors in necrotizing fasciitis and myositis: Analysis of 16 consecutive cases at a single institution in Switzerland. Ann. Plast. Surg. 2007, 58, 523–530. [Google Scholar] [CrossRef]
  24. Caravaggi, C.; Cimmino, M.; Caruso, S.; Dalla Noce, S. Intramedullary compressive nail fixation for the treatment of severe charcot deformity of the ankle and rear foot. J. Foot Ankle Surg. 2006, 45, 20–24. [Google Scholar] [CrossRef] [PubMed]
  25. Yoon, J.; Gebran, S.; Nam, A.; Brandao, R.; Wynes, J. Necrotizing fasciitis in charcotmarie-tooth treated with debridement, free flap, and extra-articular reconstruction. J. Am. Podiatr. Med. Assoc 2023, 113, 20-281. [Google Scholar] [CrossRef]
  26. Iacopi, E.; Coppelli, A.; Goretti, C.; Piaggesi, A. Necrotizing fasciitis and the diabetic foot. Int. J. Low. Extrem. Wounds 2015, 14, 316–327. [Google Scholar] [CrossRef] [PubMed]
  27. Goh, T.; Goh, L.G.; Ang, C.H.; Wong, C.H. Early diagnosis of necrotizing fasciitis. J. Br. Surg. 2014, 101, e119–e125. [Google Scholar] [CrossRef]
  28. Somasundaram, J.; Wallace, D.L.; Cartotto, R.; Rogers, A.D. Flap coverage for necrotising soft tissue infections: A systematic review. Burns 2021, 47, 1608–1620. [Google Scholar] [CrossRef]
  29. Schusterman, M.A.; Miller, M.J.; Reece, G.P.; Kroll, S.S.; Marchi, M.; Goepfert, H. A single center’s experience with 308 free flaps for repair of head and neck cancer defects. Plast. Reconstr. Surg. 1994, 93, 479–480. [Google Scholar] [CrossRef]
  30. Demirag, B.; Tirelioglu, A.; Sarisozen, B.; Durak, K. Necrotizing fasciitis in the lower extremity secondary to diabetic wounds. Acta Orthop. Traumatol. Turc. 2004, 38, 195–199. [Google Scholar]
  31. Chick, L.R.; Walton, R.L.; Reus, W.; Sasmor MColen, L. Free flaps in the elderly. Plast. Reconstr. Surg. 1992, 90, 87–94. [Google Scholar] [CrossRef] [PubMed]
  32. Bridger, A.G.; O’Brien, C.J.; Lee, K.K. Advanced patient age should not preclude the use of free-flap reconstruction for head and neck cancer. Am. J. Surg. 1994, 168, 425–428. [Google Scholar] [CrossRef] [PubMed]
  33. Randall, K.L.; Booth, B.A.; Miller, A.J.; Russell, C.B.; Laughlin, R.T. Use of an acellular regenerative tissue matrix in combination with vacuum-assisted closure therapy for treatment of a diabetic foot wound. J. Foot Ankle Surg. 2008, 47, 430–433. [Google Scholar] [CrossRef] [PubMed]
  34. Fugitt, J.B.; Puckett, M.L.; Quigley, M.M.; Kerr, S.M. Necrotizing fasciitis. Radiographics 2004, 24, 1472–1476. [Google Scholar] [CrossRef]
  35. Matsumine, H.; Fujimaki, H.; Takagi, M.; Shimizu, M.; Takeuchi, M. Reconstruction of lower limb necrotizing fasciitis by hydrosurgical debridement and multiperforator anterolateral thigh flap. Plast. Reconstr. Surg. Glob. Open 2020, 8, e3150. [Google Scholar] [CrossRef]
  36. Saad, N.; McGill, M.; Karamitros, G.; Cromack, D.; Wang, H.; Fisher, S.; Karamanos, E. Surface to perforator index: Assessing the importance of the number of perforators in successful harvesting of the anterolateral thigh flap. J. Reconstr. Microsurg. 2024, 40, 392–397. [Google Scholar] [CrossRef]
  37. Singh, B.; Cordeiro, P.G.; Santamaria, E.; Shaha, A.R.; Pfister, D.G.; Shah, J.P. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast. Reconstr. Surg. 1999, 103, 403–411. [Google Scholar] [CrossRef]
  38. Misiakos, E.P.; Bagias, G.; Patapis, P.; Sotiropoulos, D.; Kanavidis, P.; Machairas, A. Current concepts in the management of necrotizing fasciitis. Front. Surg. 2014, 1, 36. [Google Scholar] [CrossRef]
  39. Fischer, J.P.; Wink, J.D.; Nelson, J.A.; Cleveland, E.; Grover, R.; Wu, L.C.; Levin, L.S.; Kovach, S.J. A retrospective review of outcomes and flap selection in free tissue transfers for complex lower extremity reconstruction. J. Reconstr. Microsurg. 2013, 29, 407–416. [Google Scholar]
  40. Serra, P.L.; Boriani, F.; Khan, U.; Atzeni, M.; Figus, A. Rate of free flap failure and return to the operating room in lower limb reconstruction: A systematic review. J. Clin. Med. 2024, 13, 4295. [Google Scholar] [CrossRef]
  41. Kozusko, S.D.; Liu, X.; Riccio, C.A.; Chang, J.; Boyd, L.C.; Kokkalis, Z.; Konofaos, P. Selecting a free flap for soft tissue coverage in lower extremity reconstruction. Injury 2019, 50, S32–S39. [Google Scholar] [CrossRef] [PubMed]
  42. Boey, J.; Yu, L.; Hui, Z.; Meng, F.; Wan, S.; Xiao, Y.; Zhegang, Z. The limb salvage approach for the surgical management of necrotizing soft tissue infection. Plast. Reconstr. Surg. Glob. Open 2023, 11, e5207. [Google Scholar] [CrossRef]
  43. Daniel, R.K.; Taylor, G.I. Distant transfer of an island flap by microvascular anastomoses. Plast. Reconstr. Surg. 1973, 52, 111–117. [Google Scholar] [CrossRef] [PubMed]
  44. O’Brien, B.M.; MacLeod, A.M.; Hayhurst, J.W.; Morrison, W.A. Successful transfer of a large island flap from the groin to the foot by microvascular anastomoses. Plast. Reconstr. Surg. 1973, 52, 271–278. [Google Scholar] [CrossRef] [PubMed]
  45. Corbitt, C.; Skoracki, R.J.; Yu, P.; Hanasono, M.M. Free flap failure in head and neck reconstruction. Head Neck 2014, 36, 1440–1445. [Google Scholar] [CrossRef]
  46. Novakovic, D.; Patel, R.S.; Goldstein, D.P.; Gullane, P.J. Salvage of failed free flaps used in head and neck reconstruction. Head Neck Oncol. 2009, 1, 33. [Google Scholar] [CrossRef]
  47. Foley, W.D.; Stonely, T. Ct angiography of the lower extremities. Radiol. Clin. 2010, 48, 367–396. [Google Scholar] [CrossRef] [PubMed]
  48. Godina, M. Early microsurgical reconstruction of complex trauma of the extremities. Plast. Reconstr. Surg. 1986, 78, 285–292. [Google Scholar] [CrossRef]
  49. Lee, Z.-H.; Stranix, J.T.; Rifkin, W.J.; Daar, D.A.; Anzai, L.; Ceradini, D.J.; Thanik, V.; Saadeh, P.B.; Levine, J.P. Timing of microsurgical reconstruction in lower extremity trauma: An update of the godina paradigm. Plast. Reconstr. Surg. 2019, 144, 759–767. [Google Scholar] [CrossRef]
  50. Karamitros, G.; Grant, M.P.; Lamaris, G.A. Enhancing the QUINTET study: Exploring quality of life after open lower limb trauma while strengthening research methodology. J. Plast. Reconstr. Aesthetic Surg. 2025, 100, 34–35. [Google Scholar] [CrossRef]
  51. Jiang, S.; Li, M.; Fu, T.; Shan, F.; Jiang, L.; Shao, Z. Clinical characteristics of infections caused by streptococcus anginosus group. Sci. Rep. 2020, 10, 9032. [Google Scholar] [CrossRef] [PubMed]
  52. Zhao, G.-J.; Hong, G.-L.; Liu, J.-Q.; Lu, Y.; Lu, Z.-Q. Septic shock due to community-acquired pseudomonas aeruginosa necrotizing fasciitis: A case report and literature review. Exp. Ther. Med. 2014, 7, 1545–1548. [Google Scholar] [CrossRef] [PubMed]
  53. Breidung, D.; Malsagova, A.T.; Loukas, A.; Billner, M.; Aurnhammer, F.; Reichert, B.; Megas, I.F. Causative micro-organisms in necrotizing fasciitis and their influence on inflammatory parameters and clinical outcome. Surg. Infect. 2023, 24, 46–51. [Google Scholar] [CrossRef]
  54. McGhee, J.T.; Cooper, L.; Orkar, K.; Harry, L.; Cubison, T. Systematic review: Early versus late dangling after free flap reconstruction of the lower limb. J. Plast. Reconstr. Aesthetic Surg. 2017, 70, 1017–1027. [Google Scholar] [CrossRef] [PubMed]
  55. Bonapace-Potvin, M.; Govshievich, A.; Tessier, L.; Karunanayake, M.; Tremblay, D. Chollet Canadian trends in free flap management for microsurgical lower limb reconstruction. Plast. Surg. 2023, 31, 70–77. [Google Scholar] [CrossRef]
  56. Krijgh, D.D.; Teunis, T.; Schellekens, P.; Mureau, M.; Luijsterburg, A.; Tempelman, T.; van Der Beek, E.; Maarse, W.; Coert, J.H. Is dangling of the lower leg after a free flap reconstruction necessary? study protocol for a large multicenter randomized controlled study. Trials 2019, 20, 558. [Google Scholar] [CrossRef]
  57. Geoghegan, L.; Henton, J.M.D.; Kwasnicki, R.M.; Jain, A. Dangling regimes after free flap reconstruction of the lower limb; further evidence is required. J. Plast. Reconstr. Aesthetic Surg. 2018, 71, 453–454. [Google Scholar] [CrossRef]
  58. Lee, Z.H.; Ramly, E.P.; Alfonso, A.R.; Daar, D.A.; Kaoutzanis, C.; Kantar, R.S.; Thanik, V.; Saadeh, P.B.; Levine, J.P. Dangle protocols in lower extremity reconstruction. J. Surg. Res. 2021, 266, 77–87. [Google Scholar] [CrossRef]
  59. Jokuszies, A.; Neubert, N.; Herold, C.; Vogt, P.M. Early start of the dangling procedure in lower extremity free flap reconstruction does not affect the clinical outcome. J. Reconstr. Microsurg. 2013, 29, 027–032. [Google Scholar]
  60. Yim, G.H.; Pikturnaite, J.; Harry, L.; Clement, R.; Pope-Jones, S.; Emam, A.; Marsden, N. Enhanced recovery for acute open lower limb fracture ‘fix and flap’. Injury 2024, 55, 111234. [Google Scholar] [CrossRef]
  61. Berner, J.E.; Will, P.; Geoghegan, L.; Troisi, L.; Nanchahal, J.; Jain, A. Safety and effectiveness of early compression of free flaps following lower limb reconstruction: A systematic review. J. Plast. Reconstr. Aesthetic Surg. 2020, 73, 1604–1611. [Google Scholar] [CrossRef] [PubMed]
  62. Neubert, N.; Vogt, P.M.; May, M.; Boyce, M.; Koenneker, S.; Budde, E.; Jokuszies, A. Does an early and aggressive combined wrapping and dangling procedure affect the clinical outcome of lower extremity free flaps?—A randomized controlled prospective study using microdialysis monitoring. J. Reconstr. Microsurg. 2016, 32, 262–270. [Google Scholar] [PubMed]
  63. Kolbenschlag, J.; Bredenbroeker, P.; Lehnhardt, M.; Daigeler, A.; Fischer, S.; Harati, K.; Ring, A.; Goertz, O. Advanced microcirculatory parameters of lower extremity free flaps during dangling and their influencing factors. J. Reconstr. Microsurg. 2015, 31, 500–507. [Google Scholar]
  64. Krijgh, D.D.; List, E.B.; Qiu, S.S.; Schols, R.M.; Mureau, M.; Luijsterburg, A.; Tempelman, T.M.T.; van der Beek, E.S.J.; Coert, J.H.; Teunis, T.; et al. Does controlled, gradually increased venous pressure exposure (dangling) of the lower extremity after free flap reconstructions reduce partial flap loss? a multicenter randomized controlled trial. Plast. Reconstr. Surg. 2024, 10-1097. [Google Scholar] [CrossRef]
  65. Danforth, R.; Wiebe, J.E.; Socas, J.; Lester, M.E.; Hassanein, A.H. Postoperative day 1 dangling protocol with tissue oximetry guidance decreases hospital stay in lower extremity fasciocutaneous free flaps: Early experience. Plast. Reconstr. Surg. Glob. Open 2024, 12, e6097. [Google Scholar] [CrossRef]
  66. Soteropulos, C.E.; Chen, J.T.; Poore, S.O.; Garland, C.B. Postoperative management of lower extremity free tissue transfer: A systematic review. J. Reconstr. Microsurg. 2019, 35, 001–007. [Google Scholar] [CrossRef]
  67. Orseck, M.J.; Smith, C.R.; Kirby, S.; Trujillo, M. Early ambulation after microsurgical reconstruction of the lower extremity. Ann. Plast. Surg. 2018, 80, S362–S364. [Google Scholar] [CrossRef] [PubMed]
  68. Drug Overdose Deaths: Facts and Figures. 2024. Available online: https://nida.nih.gov (accessed on 23 December 2024).
  69. Busby, E.M.; Weyh, A.M.; Warrick, M.D.; Bunnell, A.M.; Fernandes, R.P. Communication: Regional anesthesia perioperative analgesia for free flap reconstruction. J. Plast. Reconstr. Aesthetic Surg. 2021, 74, 2392–2442. [Google Scholar] [CrossRef]
  70. Le, J.M.; Gigliotti, J.; Sayre, K.S.; Morlandt, A.B.; Ying, Y.P. Supplemental regional block anesthesia reduces opioid utilization following free flap reconstruction of the oral cavity: A prospective, randomized clinical trial. J. Oral Maxillofac. Surg. 2023, 81, 140–149. [Google Scholar] [CrossRef]
  71. Collins, A.B.; Gray, A.T. Peripheral nerve blocks. Basics Anesth. 2011, 1, 284–299. [Google Scholar]
  72. Town, C.J.; Strand, H.; Johnson, J.; Van Zundert, A. Ultrasound-guided axillary brachial plexus block for the management of graft site pain during dressing change in the burn-injured patient: A randomized control trial. J. Burn Care Res. 2023, 44, 53–57. [Google Scholar] [CrossRef] [PubMed]
  73. Agostini, T.; Lazzeri, D.; Spinelli, G. Anterolateral thigh flap thinning: Techniques and complications. Ann. Plast. Surg. 2014, 72, 246–252. [Google Scholar] [CrossRef] [PubMed]
  74. Park, S.O.; Chang, H.; Imanishi, N. Anatomic basis for flap thinning. Arch. Plast. Surg. 2018, 45, 298–303. [Google Scholar] [CrossRef]
  75. Marchesi, A.; Marcelli, S.; Parodi, P.C.; Perrotta, R.E.; e Riccio, M.; Vaienti, L. Necrotizing fasciitis in aesthetic surgery: A review of the literature. Aesthetic Plast. Surg. 2017, 41, 352–358. [Google Scholar] [CrossRef] [PubMed]
  76. Karamitros, G.; Lamaris, G.A.; Goulas, S. “US air pollution and increased incidence of non-syndromic cleft lip/palate”: Association does not imply causality. J. Plast. Reconstr. Aesthetic Surg. 2024, 90, 23–24. [Google Scholar] [CrossRef]
  77. Ioannidis, J.P.A.; Hozo, I.; Djulbegovic, B. Optimal type i and type ii error pairs when the available sample size is fixed. J. Clin. Epidemiol. 2013, 66, 903–910. [Google Scholar] [CrossRef]
  78. Sanders, G.D.; Maciejewski, M.L.; Basu, A. Overview of cost-effectiveness analysis. JAMA 2019, 321, 1400–1401. [Google Scholar] [CrossRef]
Figure 1. A 35 y.o. M developed necrotizing soft tissue infection of the left lower extremity following an elective endoscopic repair of torn anterior cruciate ligament of the knee. After multiple debridement, he had a circumferential wound spanning from the distal thigh to the ankle with exposed critical structures necessitating soft tissue reconstruction.
Figure 1. A 35 y.o. M developed necrotizing soft tissue infection of the left lower extremity following an elective endoscopic repair of torn anterior cruciate ligament of the knee. After multiple debridement, he had a circumferential wound spanning from the distal thigh to the ankle with exposed critical structures necessitating soft tissue reconstruction.
Jcm 14 02997 g001
Figure 2. Post-operative appearance of wound 8 months following reconstruction. A musculocutaneous anterolateral thigh (ALT) flap was used (36 × 11 cm skin island and 16 × 6 cm vastus lateralis muscle) to cover the exposed bony structures of the knee and leg, while the posterior aspect of the leg was covered with a split thickness skin graft. At the time of the last follow-up (8 months), the patient had already returned to playing sports and was able to resume all his regular daily activities.
Figure 2. Post-operative appearance of wound 8 months following reconstruction. A musculocutaneous anterolateral thigh (ALT) flap was used (36 × 11 cm skin island and 16 × 6 cm vastus lateralis muscle) to cover the exposed bony structures of the knee and leg, while the posterior aspect of the leg was covered with a split thickness skin graft. At the time of the last follow-up (8 months), the patient had already returned to playing sports and was able to resume all his regular daily activities.
Jcm 14 02997 g002
Table 1. Free Flap/Tissue Transfer (FFT) Case Series.
Table 1. Free Flap/Tissue Transfer (FFT) Case Series.
IDSexAgeHistoryLocationOrganismDays to Flap from
First Debridement
FTT TypeMuscle Flap Size,
cm × cm (cm2)
Skin Island Size,
cm × cm (cm2)
ComplicationsSurgery Time
(min)
Ischemia Time
(min)
1Male27Pyoderma
gangrenosum ulcer
L lower leg/kneeNot identified 119Chimeric ALT-VLNot specified22 × 11 (242)Infection of donor site330Not specified
2Male34Penetrating
trauma
L
foot/ankle
GABS 2 and
E.coli
19Chimeric
ALT-VL
18 × 8 (144)11 × 24 (264)None24054
3Male35Surgical site
infection
L lower
leg
Not
identified
5Chimeric
ALT-VL
16 × 6 (96)36 × 11 (396)None375Not specified
4Female65Blunt traumaL lower
leg
Not
identified
26LD38 × 23 (874)-Heamatoma
(donor site)
38265
1 Not identified: indicates cultures that had no growth. 2 Group A beta-hemolytic Streptococcus species.
Table 2. Local Flap(LF) Case Series.
Table 2. Local Flap(LF) Case Series.
IDSexAgeHistoryLocationOrganismDays to Flap
from First Debridement
LF TypeDefect Size, cm × cm (cm2)ComplicationsSurgery Time (min)
1Male37T16 paraplegia Girldstone procedureL lower leg (trochanter and
ischium)
Not identified7VL-RF10 × 14 (140)None255
2Female60Pain and rednessL lower leg (upper thigh, groin,
perineum)
Eggerthia catenaformis, Streptococcus anginosus,
Schaalia radingae
17Sartorius-RF35 × 55 (1925)None126
3Female30Penetrating injury, abscess formationL lower leg (groin)Streptococcus dysgalactiae,
Arcanobacterium haemoliticum
8RF3 × 8 (24)None102
4Male43Bilateral paraplegiaL lower leg
(Ischial tuberosity)
Pseudomonas aeroginosa 30Biceps femorisNot specifiedWound
dehiscence
198
3 Multi-drug resistant, carbapenemase detected.
Table 3. Likely causative organisms in patients with NF of the lower extremities that underwent FTT compared to LF.
Table 3. Likely causative organisms in patients with NF of the lower extremities that underwent FTT compared to LF.
GABS 4FTT (n = 4)
1 (25%)
LF (n = 4)
1 (25%) 5
S. aureus0 (0%)0 (0%)
E. coli1 (25%)0 (0%)
Other0 (0%)3 (75%)
4 GABS: Group A beta-hemolytic Streptococcus species. 5 In the LF group the GABS was a Streptococcus dysgalactiae.
Table 4. Demographic data of patients with NF of the lower extremities that underwent FFT and no FFT.
Table 4. Demographic data of patients with NF of the lower extremities that underwent FFT and no FFT.
FTT (n = 4)LF (n = 4)p Value
Age (±SD)39.25 ± 15.5942.5 ± 11.10.78
Sex (male)3 (75%)2 (50%)0.47
Surgery duration
(min ± SD)
331.75 ± 56.61170.25 ± 60.350.015
Days of hospital stay
(total)
34.75 ± 17.627.71 ± 18.710.65
Total number of
operations
7.75 ± 5.365.5 ± 5.590.63
Days from admission
to flap surgery
17.25 ± 7.638 ± 6.040.15
Surgeries before flap4.25 ± 2.862.5 ± 2.290.44
Positive smoking
status
1/4 (25%)3/4 (75%)0.16
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Karamitros, G.; Grant, M.P.; Henry, S.; Lamaris, G.A. Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands—A Case Series from a Tertiary Referral Center. J. Clin. Med. 2025, 14, 2997. https://doi.org/10.3390/jcm14092997

AMA Style

Karamitros G, Grant MP, Henry S, Lamaris GA. Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands—A Case Series from a Tertiary Referral Center. Journal of Clinical Medicine. 2025; 14(9):2997. https://doi.org/10.3390/jcm14092997

Chicago/Turabian Style

Karamitros, Georgios, Michael P. Grant, Sharon Henry, and Gregory A. Lamaris. 2025. "Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands—A Case Series from a Tertiary Referral Center" Journal of Clinical Medicine 14, no. 9: 2997. https://doi.org/10.3390/jcm14092997

APA Style

Karamitros, G., Grant, M. P., Henry, S., & Lamaris, G. A. (2025). Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands—A Case Series from a Tertiary Referral Center. Journal of Clinical Medicine, 14(9), 2997. https://doi.org/10.3390/jcm14092997

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop